Orthofix also reported net income of $14.0 million for this quarter, up from $10.5 million in the prior year. The company also reported 7 percent growth in net sales for its spine business to $81.8 million, while net sales from its orthopedic business decreased 6 percent to $37.7 million.
During the second quarter, increased adoption of the Trinity Evolution in spine applications led to a 48 percent increase in sales of the regenerative biologics business.
More Articles on Orthopedic Devices:
Minimally Invasive Surgery Market to Reach $35.5B by 2016
MiMedx Revenues Reach $4.9M in 2Q, 153% Increase
China Device Market Expected Grew at 20.5% CAGR From 2006-2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.